Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SPIRO-ARYL-PHOSPHORUS-OXYGEN COMPOUND AS FOURTH GENERATION OF EGFR KINASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2018/108064
Kind Code:
A1
Abstract:
Disclosed are a fourth generation (T790M/C797S mutation) of an EGFR kinase inhibitor, i.e. a spiro-aryl-phosphorous-oxygen compound, in particular a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof, used for treating cancers.

Inventors:
WU LINGYUN (CN)
LIU XILE (CN)
DING CHARLES Z (CN)
CHEN SHUHUI (CN)
HU LIHONG (CN)
ZHAO LELE (CN)
PAN WEI (CN)
HU GUOPING (CN)
LI JIAN (CN)
Application Number:
PCT/CN2017/115577
Publication Date:
June 21, 2018
Filing Date:
December 12, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07F9/53; A61K31/66; A61P35/00; C07D221/20; C07D471/04; C07D471/10; C07D487/10
Foreign References:
CN102105150A2011-06-22
CN103501612A2014-01-08
CN104130265A2014-11-05
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: